Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
about
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseFDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicityA review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Anti-diabetic and anti-Alzheimer's disease activities of Angelica decursiva.Acetylcholinesterase protein level is preserved in the Alzheimer's brain.Fatty acid composition and biological activities of Isochrysis galbana T-ISO, Tetraselmis sp. and Scenedesmus sp.: possible application in the pharmaceutical and functional food industries
P2860
Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@ast
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@en
type
label
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@ast
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@en
prefLabel
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@ast
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@en
P2093
P2860
P1476
Biochemical differentiation of ...... nd Alzheimer's disease cortex.
@en
P2093
Alexis Ciro
Changiz Geula
Gary Burkhard
Nicole Yan
P2860
P304
P356
10.2174/156720512799015127
P577
2012-01-01T00:00:00Z